EFFECT OF A SELECTIVE C5AR ANTAGONIST, AVACOPAN (CCX168), ON PLASMA COMPLEMENT LEVELS IN ANCA ASSOCIATED VASCULITIS (AAV)

Bunch, DO; Deng, J; McInnis, EA; Bekker, P; Hillson, JL; Schall, TJ; Jennette, CJ; Nachman, P; Deng, J

ANNALS OF THE RHEUMATIC DISEASES, 2018; 77 (): 74